If you hate needles but need a vaccination, MIT might have your back. A recent MIT News article discussed the development of a new type of vaccination that is inhaled directly into the lungs to increase immune responses to respiratory infections or lung cancer. Mucosal surfaces, such as the lining of the respiratory tract, are often the host for viruses. A team of researchers at MIT created a strategy to build up an army of T cells that waits on such surfaces to offer a quick response to viruses.
MIT is Developing Vaccination by Inhalation
The new method creates an army of T cells on a mucosal surface that attack viruses.
Mar 31, 2021
Recommended
Recommended
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
